DavidGPfisterMD

Clinical Trials

• Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] Start of enrollment: 1998 Jul 01

  Terminated

• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Start of enrollment: 1998 Jul 01

  Completed

  Phase 2

• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck Start of enrollment: 2000 Dec 01

  Completed

  Phase 2

• Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Start of enrollment: 2003 Nov 01

  Completed

  Phase 3

• Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine Start of enrollment: 2004 Oct 01

  Completed

  Phase 2

• A Randomized Study of Sulindac in Oral Premalignant Lesions Start of enrollment: 2006 Feb 23

  Completed

  Not Applicable

• Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors Start of enrollment: 2006 Nov 01

  Completed

  Phase 1

• Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 2

• Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2007 Jul 01

  Completed

  Phase 2

• A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) Start of enrollment: 2006 Sep 01

  Completed

  Phase 2

• Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Start of enrollment: 2008 Aug 01

  Completed

  Phase 2

• Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) Start of enrollment: 2009 Nov 01

  Completed

  Phase 1, Phase 2

• Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma Start of enrollment: 2010 Dec 28

  Completed

  Not Applicable

• Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) Start of enrollment: 2014 Oct 30

  Completed

  Phase 1

• Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers Start of enrollment: 2020 Jun 02

  Recruiting

  Phase 2

• PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Start of enrollment: 2020 Sep 02

  Active, not recruiting

  Phase 2

• A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer Start of enrollment: 2021 Jan 20

  Recruiting

  Phase 1

• Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer Start of enrollment: 2020 Jan 20

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all